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Continued medical education: 
Hypertension and systolic dysfunction (day case) 
Dr Noel CARUANA 
Presentation 
Mrs Grech, a 61 year lady woman was accompanied to my 
clinic by her daughter due to progressive dyspnoea. She had 
enjoyed good health until3 months previously when she started 
to complain from exertional dyspnoea with minimal activity. Lately 
this complaint was accompanied by an increase in her weight 
and some swelling of her feet. Since the previous week her 
dyspnoea worsened and she noted orthopnea and some chest 
discomfort. She had been an ex-smoker since 7 years and did 
not abuse alcohol. She had also been on antihypertensive 
treatment for over 10 years but with poor blood pressure control. 
She was taking atenololl OOmg and hydrochlorothiazide 50 mg 
daily 
Clinical examination 
She was obese (weight 79 kg, height 157cm) and tachypneic 
at 39 respirations per minute. Her BP was 165/95 mm Hg, with 
a regular tachycardia at 105 bpm. There were no carotid bruits 
but the jugular pressure was raised. Cardiac examination showed 
a laterally displaced apex beat at the sixth intercostal space, a 2/ 
6 systolic murmur and a third heart sound. Lung auscultation 
revealed significant bilateral crepitations. She had pitting oedema 
ofher legs, with normal pedal pulses. The rest of the examination 
was unremarkable. 
Investigations 
A chest X ray showed significant cardiomegaly and pulmonary 
oedema (Figure 1). On ECG, there was sinus tachycardia and a 
complete LBBB (Figure 2). Routine haematological and blood 
chemistry were normal except for an elevated cholesterol (total 
cholesterol: 7.9mmol/l, LDL: 5.lmmol/l, HDL: o 98mmol/l) and 
triglycerides 32mmoVl. 
Management 
This lady was treated with an initial dose of IV frusemide 
and started on oral ACE inhibitor (enalaprill Omg daily) , a diuretiċ 
(bumetanide 2mg daily) and aspirin 75mg daily (which was 
changed to a coumarin after the echocardiogram confirmed 
regurgitation). She was referred to a cardiologist who performed 
an echocardiogram which showed marked left ventricular 
hypertrophy (LVH) , septum 12mm, posterior wall llmm and 
left ventricle end-diastolic diameter 70mm. There was also 
evidence of marked global systolic dysfunction, with an ejection 
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regurgitation and mild tricuspid regurgitation. Systolic pulmonary 
pressure was 48 mm Hg. 
At a second review two weeks later, she was found to have 
no tachypnoea and no chest discomfort and a BP of 145/ 90. 
The ACE inhibitor dose was increased to 20mg daily and the 
diuretic dose was decreased to l mg daily, a statin was also added 
in view of hypercholesterolaemia. An angiogram was booked to 
rule out ischaemic disease. 
Questions 
1. How does congestive heart failure develop during 
hypertension? 
2. How could hypertensive heart disease be detected in such a 
patient? 
3. What is the best treatment protocol and the prognosis for 
this patient? 
Answers on page 41 After reviewing the answers you can claim l 
CME point by quoting code MFD/CME 001 on your app1ication 
fraction of about 22% There was also moderate mitral foraccreditation. 
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Answers to questions on Page 13 
l. Hypertension is known to be the most common risk factor but can occur in up to 30% of patients over 60. CT scanning 
for congestive heart failure(CHF). Although systolic function and magnetic resonance imaging provide high definition 
is usually preserved in hypertensive heart disease, diastolic measurements of cardiac function and size but are not 
function soon becomes abnormal causing pressure overload. indicated for routine use. 
The deterioration from left ventricular hypertrophy (lVH) 
with compensated cardiac function, to symptomatic CHF 3. Results of clinical trials done in the 1990s show that adding 
may be imperceptible, but diastolic filling is usually impaired. an ACE inhibitor to standard treatment decreases the high 
End stage hypertensive heart disease is characterized by risk of hospitalizations and mortality related to CHF The 
systolic dysfunction, with dramatic worsening of symptoms. CONSENSUS trial in patients with severe heart failure 
Reduction of BP often results in dramatic improvement in demonstrated a 12 month mortality rate of 52% in the 
clinical symptoms. One must always rule out other causes placebo group compared to 36% in the enalapril 
of CHF such as occlusive coronary artery disease, hence the group(RR31 %) . Mortality 18tes in patients NYHA class II of 
need for an angiogram in this case (apart from the fact that III in the placebo and enalapril groups of the SOlVD trial 
presence of a lBBB renders ECG interpretation of ischaemic were 39.7% and 35.2% respectively. 
changes dubious). Recently, blockers and spironolactone have also been shown 
to reduce mortality when added to AtE inhibitors, digoxin 
2. Identification of hypertensive heart disease rests on proper and diuretics. More recently stil!, ARBs have been marketed 
clinical assessment and non invasive diagnostic investigations. to replace ACE inhibitors in those patients with cough 
One may suspect lV dilatation and systolic dysfunction by problems. Although we have a vast array of treatments which 
finding lateral displacement of the apical impulse (from the have evolved over the recent years allowing a better quality 
5th intercostal space, 8-9cm from the mid-line) and the of life to our patients with CHF, the morbidity and mortality 
presence of a third heart sound. A sustained apical impulse rates of patients with CHF remain stil! exceedingly high. 
and a fourth heart sound may suggest lVH. 
Some experience with ECG interpretation may be rewarding References and Further Reading 
by finding evidence of lVH and left atrial enlargement, the 
latter is a good sign ref1ecting diastolic dysfunction. The ECG Aeschbacher SC, HU[ter D, Fuhrer J, et Pin B, Zannad F, Remme WJ, et al. The 
also provides good information on arrhythmias, defective al. Diasrolic dysfunction precedes 
effecr of spironolacrone on morbidiry 
myocardial hypenrophy in the and monaliry in patienrs with severe 
conduction and ischemic changes. Echocardiography is as developmenr of hyperrension. AmJ hean failure. New EnglandJ 
~xcellent tool to diagnose hypertensive heart disease. It gives Hypenension.2001;14:106-113. 
Med.1999;341709-717. 
good information about the structure of the lV and Packer M, Brisrow MR, CohnJN, et al. Frohlich ED, Apstein C, Chobanian AY, 
determines the presence of lVH and its geometric model, The effect of carvedilol on morbidiry et al. The hem in hyperrension. New 
and monaliry in parienrs with chronic EnglandJ Med. 1992;327:998-1008. 
whether it is concentric or eccentric. Concentric lVH is the hean failure. US Carvedilol Hean 
predominant form in the elderly and middle- aged patients Failure Study Group. New EnglandJ 
whereas eccentric lVH is uncommon in those under 50 years Med. 1996;334:1349-1355. 
CME in future editions 
In accordance with the mission statement of this joumal, the CME section is intended to offer an opponunity to discuss issues encountered 
in the daily practice of famliy medicine. It is hoped that in the future this section will be developed funher allowing one to assess and challenge his/ 
her own level of knowledge. 
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